Ertapenem Sodium
Generic Name: ertapenem sodium
Brand Names:
Ertapenem
Ertapenem sodium is a sterile, synthetic carbapenem antibiotic for parenteral administration, indicated for moderate to severe bacterial infections.
Overview
Ertapenem sodium is a sterile, synthetic carbapenem antibiotic for parenteral administration, indicated for moderate to severe bacterial infections.
Uses
Treatment of moderate to severe infections in adults and pediatric patients (3+ months): complicated intra-abdominal infections, skin/skin structure infections, community-acquired pneumonia, urinary tract infections, acute pelvic infections, and surgical site infection prophylaxis for colorectal surgery.
Dosage
Adults/pediatrics 13+: 1 gram daily IV/IM. Ages 3 months-12 years: 15 mg/kg twice daily (max 1 gram/day). IV infusion over 30 minutes for up to 14 days or IM for up to 7 days.
Side Effects
Most common: diarrhea, nausea, headache, infused vein complication in adults. Diarrhea, vomiting, infusion site pain in pediatrics.
Interactions
Probenecid reduces renal clearance. Valproic acid/divalproex sodium interaction increases seizure risk.
Warnings
Hypersensitivity reactions, seizure potential, valproic acid interaction, C. difficile-associated diarrhea. Contraindicated in known hypersensitivity to product components or anaphylactic reactions to beta-lactams, and amide local anesthetic hypersensitivity for IM use.
Pregnancy
Animal studies showed no developmental malformations at therapeutic exposures. Limited human data available.
Frequently Asked Questions
What is Ertapenem Sodium used for?▼
Treatment of moderate to severe infections in adults and pediatric patients (3+ months): complicated intra-abdominal infections, skin/skin structure infections, community-acquired pneumonia, urinary tract infections, acute pelvic infections, and surgical site infection prophylaxis for colorectal surgery.
What are the side effects of Ertapenem Sodium?▼
Most common: diarrhea, nausea, headache, infused vein complication in adults. Diarrhea, vomiting, infusion site pain in pediatrics.
Can I take Ertapenem Sodium during pregnancy?▼
Animal studies showed no developmental malformations at therapeutic exposures. Limited human data available.
What are the important warnings for Ertapenem Sodium?▼
Hypersensitivity reactions, seizure potential, valproic acid interaction, C. difficile-associated diarrhea. Contraindicated in known hypersensitivity to product components or anaphylactic reactions to beta-lactams, and amide local anesthetic hypersensitivity for IM use.
Related Medications
Naphazoline Hydrochloride And Glycerin
naphazoline hydrochloride and glycerin
Non-Standardized Chemical Allergen [EPC]
Purpose Lubricant
Calcarea Sulphurica, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Cerebellum (suis), Gallbladder (bovine), Heart (bovine), Hepar (bovine), Hypothalamus Suis, Intestine (suis), Kidney (bovine), Lung (bovine), Medulla Ossis Suis, Pancreas Suis, Pineal Gland (suis), Rectal Mucosa (suis), Spleen (bovine), Stomach (suis), Thymus (ovine), Thyroidinum (bovine), Urinary Bladder (suis), Pituitarum Posterium (bovine), Acetyl Coenzyme A,
calcarea sulphurica, kali muriaticum, kali phosphoricum, kali sulphuricum, natrum muriaticum, natrum phosphoricum, natrum sulphuricum, cerebellum (suis), gallbladder (bovine), heart (bovine), hepar (bovine), hypothalamus suis, intestine (suis), kidney (bovine), lung (bovine), medulla ossis suis, pancreas suis, pineal gland (suis), rectal mucosa (suis), spleen (bovine), stomach (suis), thymus (ovine), thyroidinum (bovine), urinary bladder (suis), pituitarum posterium (bovine), acetyl coenzyme a,
Amino Acid [EPC]
PURPOSE: Aids in providing balance in endocrine system and in amino acid, electrolyte and intermediary metabolism.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Ledipasvir And Sofosbuvir
ledipasvir and sofosbuvir
Hepatitis C Virus NS5A Inhibitor [EPC]
11 DESCRIPTION Ledipasvir and sofosbuvir tablets (90 mg/400 mg) are fixed-dose combination tablets containing ledipasvir and sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase. Each tablet contains 90 mg ledipasvir and 400 mg sofosbuvir.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.